
2022 Speakers

David Acheson
Senior Vice President, North America, Apellis Pharmaceuticals

Tera Roy Ackerman
Sr. Vice President, Nextech Systems

Laurent Attias
Senior Vice President, Corporate Development Strategy, BD&L and M&A, Alcon

Robert L. Avery, MD
California Retina Consultants

Bobak Azamian, MD, PhD
CEO, Tarsus Pharmaceuticals

Scott Barnes, MD
Chief Medical Officer, STAAR Surgical

Kerrie Brady
President and Chief Executive Officer, OcuTerra Therapeutics

Tara Capalbo
General Manager, Glaucoma, Allergan, an AbbVie Company

Bill Carpou
CEO, Octane

Arturo Chayet, MD
Codet Vision Institute

Alan Crunkleton
President and CEO, IOPtic, Inc.

Jag Dosanjh
President, U.S. Neuroscience and Eyecare, AbbVie

Andrew Douglas
Partner, Knobbe Martens

Daniel Durrie, MD
Chairman, iOR Partners, Founder, Durrie Vision

David Endicott
CEO, Alcon

Sanjeev Ganatra
SVP, Sales & Marketing

Ranya Habash MD
CEO, LifeLong Vision; FDA Digital Health Network of Experts, Medical Director, Technology Innovation, Bascom Palmer Eye Institute

Mark Hagler
Senior Vice President, Head, Ophthalmics, Oncology & Radiopharma

Chuck Hess
Vice President of Global Commercial Development and Digital Health, Bausch + Lomb

Mike Hill
Director, LaunchPad SBDC

Kamran Hosseini, MD, PhD
CEO, Surface Ophthalmics Inc.

John Hovanesian, MD, FACS
Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA

Mark Humayun, MD, PhD
University Professor of Ophthalmology, Director, Institute for Biomedical Therapeutics,Co-Director USC Roski Eye Institute,Director of Sensory Science Initiatives, Cornelius J. Pings Chair in Biomedical Sciences, Keck School of Medicine, USC

Sean Ianchulev, MD, MPH

Cristos Ifantides
Director, Ophthalmic Global Outreach, University of Colorado, Anschutz Medical Campus

Patrick Johnson

Bob Katz
President & CEO, ForwardVue Pharma, Inc.

Elad Kedar
CEO, Orasis Pharmaceuticals

Darius Kharabi, JD, MBA
Chief Business Officer, Kala Pharmaceuticals

Savas Komban
CEO & Co-founder, Smartlens

Greg Kunst
Chief Executive Officer, Aurion Biotech

Baruch Kuppermann, MD
Roger F. Steinert Professor and Chair, Department of Ophthalmology, School of Medicine, Director, Gavin Herbert Eye Institute School of Medicine

Bill Link, PhD
Managing Partner, Flying L Partners

Tim Lugo
Head of Biotechnology and Pharmaceutical Equity Research at William Blair

Richard Lindstrom, MD
Minnesota Eye Consultants

Caren Mason
President & CEO, STAAR Surgical

Cynthia Matossian MD, FACS
Founder, Matossian Eye Associates

James V. (Jim) Mazzo
Executive Chairman, Neurotech, Chief Executive Officer, Avellino Labs, Advisor, Zeiss, Advisor, Bain Consulting, Board Member, Centricity Vision Inc.

Terry McGovern
Co-Founder, Kato Pharmaceuticals

George Mimura
Chairman and CEO, SalutarisMD

Yari Mitchell
Chief Business Development Officer, AcuFocus, Inc.

Aziz Mottiwala
Chief Commercial Officer, Tarsus Pharmaceuticals

Lisa Nijm MD, JD
Warrenville Eye Care & LASIK Center

Marc Odrich MD
Chief Medical Officer, LENZ Therapeutics

Michael J. O'Rourke
CEO, Re-Vana Therapeutics

Erin Powers
Vice President, Global Marketing & Product Strategy, BVI Medical

MK Raheja, PhD
Head, Surgical Vision R&D, Johnson & Johnson Vision

Michael Rowe
Chief Operating Officer, Eyenovia Inc.

Sheri Rowen, MD, FACS
NVision Eye Centers

Ehsan Sadri, MD, FACS
Founder & CEO, Visionary Eye Institute

Michelle Senchyna, PhD
Vice President, Clinical Development and Medical Affairs, Aerie Pharmaceuticals

Nikki Sidi
Vice President, Global Strategic Marketing, Surgical Vision, Johnson & Johnson Vision

Richard Small
CEO, Neurotech Pharmaceuticals, Inc.

Euan Thomson PhD
Global President Ophthalmic Devices
Head of Digital Business Unit, Carl Zeiss Meditec

Toby Tyson, MD, FACS
Tyson Eye, Visionary Venture Fund Co-Founder

Ramin Valian
Vice President, Eye Care, Allergan, an AbbVie Company

Marty Waters
Partner, Wilson Sonsini

Jeffry Weinhuff
Managing Partner, Visionary Venture Fund

Julia Williams
Vice President of Clinical and Medical Affairs, Visus Therapeutics

Elizabeth Yeu, MD
Partner, Virginia Eye Consultants